Aridis Pharmaceuticals Inc (NASDAQ:ARDS)

1.31
Delayed Data
As of Jun 24
 -0.05 / -3.68%
Today’s Change
0.88
Today|||52-Week Range
7.72
-43.78%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2018
Quarter 3
2018
Quarter 4
2018
Quarter 1
2019
AssetsCash13.5M34.1M24.2M16.3M
 
 
 
 
 
Short Term Investment Cash-6.9M20.6M-9.8M-7.9M
 
 
 
 
 
Cash & Short Term Investments13.5M34.1M24.2M16.3M
 
 
 
 
 
 
ReceivablesReceivables0.00800.0K1.7M2.1M
 
 
 
 
 
InventoriesInventories--0.000.000.00--
 
Current AssetsOther Current Assets960.0K1.4M2.5M2.1M
 
 
 
 
 
Current Assets14.4M36.3M28.3M20.5M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross1.6M1.6M1.8M1.8M
 
 
 
 
 
Depreciation-337.0K-410.0K-491.0K-572.0K
 
 
 
 
 
Intangible Assets41.0K39.0K38.0K36.0K
 
 
 
 
 
Other Assets386.0K80.0K1.0M1.0M
 
 
 
 
 
Total Assets16.1M38.6M31.6M23.3M
 
 
 
 
 
 
LiabilitiesAccounts Payable610.0K1.8M2.3M2.7M
 
 
 
 
 
Accrued Expenses2.2M4.7M2.7M1.7M
 
 
 
 
 
Other Current Liabilities2.9M5.2M2.7M1.7M
 
 
 
 
 
Other Liabilities5.1M7.2M5.3M4.5M
 
 
 
 
 
 
Total LiabilitiesOther Liabilities8.8M0.000.000.00
 
 
Total Liabilities13.9M7.2M5.3M4.5M
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock74.2M0.000.000.00
 
 
Common Equity-72.0M31.4M26.3M18.7M
 
 
 
 
 
Total Shareholder Equity2.2M31.4M26.3M18.7M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding8.2M8.1M8.1M8.1M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.